glp-1 and protein intake weight loss drugs leave users low on key nutrients, study finds Nutritional Side Effects of GLP-1

In the head-to-head SURMOUNT trial, funded by drug manufacturer Eli Lilly, people who took tirzepatide lost more weight than those who took semaglutide (Ozempic)

doi:10.1021/jm00132a010 Return to citation in text: [1] [2] [3] Al-Obeidi, F

Acidification prevents endothelial cell apoptosis by Axl activation

245 unveiled the importance of the interaction between CBP/p300 and SRC1 through its activation domain 1 (AD1) in assisting the recruitment of CBP/p300 to the estrogen receptor

While the magnitude of these benefitsa 10% to 20% reduction in many outcomesis modest, the implications are profound for conditions with limited treatment options

Bioavailability enhancers of herbal origin: An overview